Alzamend Neuro, Inc.ALZNNASDAQ
Loading
EPS Growth AcceleratingAccelerating
Percentile Rank100
Year-over-Year Change
Year-over-year earnings per share growth rate
Percentile
P100
Near historical high
vs 2Y Ago
4.3x
Strong expansion
Streak
2 qtr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| Q4 2025 | 76.56% |
| Q3 2025 | 47.33% |
| Q2 2025 | -42.94% |
| Q1 2025 | 52.91% |
| Q4 2024 | 68.39% |
| Q3 2024 | -2.51% |
| Q2 2024 | 67.21% |
| Q1 2024 | 14.76% |
| Q4 2023 | 17.63% |
| Q3 2023 | -4.92% |
| Q2 2023 | 38.10% |
| Q1 2023 | -72.95% |
| Q4 2022 | -2.40% |
| Q3 2022 | 29.20% |
| Q2 2022 | -61.05% |
| Q1 2022 | 29.06% |
| Q4 2021 | -40.46% |
| Q3 2021 | -61.03% |
| Q2 2021 | -10.00% |
| Q1 2021 | 17.39% |
| Q4 2020 | -2.85% |
| Q3 2020 | -4.24% |
| Q2 2020 | 1.91% |
| Q1 2020 | -34.26% |
| Q4 2019 | 0.00% |
| Q3 2019 | 2.24% |
| Q2 2019 | 0.00% |
| Q1 2019 | 54.63% |
| Q4 2018 | 0.00% |
| Q3 2018 | -428.80% |
| Q2 2018 | 0.00% |
| Q1 2018 | -34.51% |
| Q4 2017 | 0.00% |
| Q3 2017 | 65.43% |
| Q2 2017 | 0.00% |
| Q1 2017 | 21.76% |
| Q4 2016 | 0.00% |
| Q3 2016 | 0.00% |